Anticonvulsant hypersensitivity syndrome associated with Bellamine S, a therapy for menopausal symptoms

Journal of the American Academy of Dermatology

Volumn 50, Issue 5 SUPPL., 2004, Pages 86-89

  Turner, Ryan B ^a,b   Kim, Caroline Choi ^a,b   Streams, Brian N ^a,b   Culpepper, Keliegh ^a,b   Haynes, Harley A ^a,b,c  

^a Harvard Medical School ^*

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; ANTIVIRUS AGENT; ASCORBIC ACID; BELLADONNA ALKALOID; BELLAMINE S; CALCIUM CARBONATE; CARBAMAZEPINE; CETIRIZINE; CLOBETASONE; CONJUGATED ESTROGEN; CORTICOSTEROID; ERGOTAMINE; IMMUNOGLOBULIN; METHYLPREDNISOLONE SODIUM SUCCINATE; PHENOBARBITAL; PHENYTOIN; PREDNISONE; PROGESTERONE;

ADULT; ANTICONVULSANT HYPERSENSITIVITY SYNDROME; ARTICLE; CASE REPORT; DRUG HYPERSENSITIVITY; ERYTHEMA; FACE EDEMA; FEMALE; HERPES ZOSTER; HISTOPATHOLOGY; HOT FLUSH; HUMAN; MENOPAUSE; PATHOGENESIS; POSTMENOPAUSE; PRIORITY JOURNAL; RASH; SKIN BIOPSY; SYNDROME DELINEATION; TOXIC EPIDERMAL NECROLYSIS; VIRUS MENINGITIS;

EID: 2342538493     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0190-9622(03)02800-7     Document Type: Article

References (17)

1. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg 1996;15:250-7.
2. Tennis P, Stern RS. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study. Neurology 1997;49:542-6.
3. Chaiken BH, Goldberg BI, Segal JP. Dilantin sensitivity: report of a case of hepatitis with jaundice, pyrexia, and exfoliative dermatitis. N Engl J Med 1950;242:897-8.
4. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;331:1275-85.
5. Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome: in vitro assessment of risk. J Clin Invest 1988;82:1826-32.
6. Yoo JH, Kang DS, Chun WH, Lee WJ, Lee AK. Anticonvulsant hypersensitivity syndrome with an epoxide hydrolase defect. Br J Dermatol 1999; 140:181-3.
7. Descamps V, Valance A, Edlinger C, Fillet AM, Grossin M, Lebrun-Vignes B, et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 2001;137: 301-4.
8. Gennis MA, Vemuri R, Burns EA, Hill JV, Miller MA, Speilberg SP. Familial occurrence of hypersensitivity to phenytoin. Am J Med 1991;91:631-4.
9. Kleier RS, Breneman DL, Boiko S. Generalized pustulation as a manifestation of the anticonvulsant hypersensitivity syndrome. Arch Dermatol 1991;127:1361-4.
10. Ploysangam T, Breneman DL, Mutasim DF. Cutaneous pseudolymphomas. J Am Acad Dermatol 1998;38:877-95.
11. D'Incan M, Souteyrand P, Bignon YJ, Fonck Y, Roger H. Hydantoin-induced cutaneous pseudolymphoma with clinical, pathologic, and immunologic aspects of Sezary syndrome. Arch Dermatol 1992; 128:1371-4.
12. Nathan DL, Belsito DV. Carbamazepine-induced pseudolymphoma with CD-30 positive cells. J Am Acad Dermatol 1998;38:806-9.
13. Green VJ, Pirmohamed M, Kitteringham NR, Gaedigk A, Grant DM, Boxer M, et al. Genetic analysis of microsomal epoxide hydrolase in patients with carbamazepine hypersensitivity. Biochem Pharmacol 1995;50:1353-9.
14. Maguire JH, Wettrell G, Rane A. Apparently normal phenytoin metabolism in a patient with phenytoin-induced rash and lymphadenopathy. Br J Clin Pharmacol 1987;24:554-7.
15. Kennebeck GA. Anticonvulsant hypersensitivity syndrome. J Am Board Fam Pract 2000;13:364-70.
16. Ginsburg ES. Hot flushes: physiology hormonal therapy and alternative therapies. Obstet Gynecol Clin North Am 1994;21:381-90.
17. Harper DC. Perimenopause and aging. In: Lichtman R, Papera S, editors. Gynecology: well-woman care. East Norwalk (CT): Appleton and Lange, 1990. p. 405-24.